Botanical guide · Ingredient reference

Devil’s claw: pain research and the limits of mixed formulas

Some small studies suggest pain-related benefits, but preparation differences and digestive risks matter when interpreting devil’s claw products.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

A root extract, not a treatment category

Devil’s claw refers to Harpagophytum procumbens, whose tuberous roots are used in supplements. Its traditional uses do not establish effectiveness for every condition included in marketing. [1]

Pain findings need a preparation match

MSK describes limited clinical evidence for osteoarthritis and back pain, including studies of formulas containing devil’s claw. Confirmatory studies are needed. A result from a combination cannot identify the contribution of this one ingredient. [1]

Reading a combination study

Imagine a trial reporting less knee pain after participants receive three ingredients. A second product contains only devil’s claw. The trial is relevant background, but it is not a direct test of the second product. The missing comparison is the single ingredient against an appropriate control under the same conditions.

Hypothetical evidence check — not a product recommendation
What a reader seesWhat it actually supports
Combination improved symptomsIndividual ingredient contribution remains unresolved
One reported adverse eventSignals a concern, not a reliable incidence estimate

Digestive and medication cautions

Indigestion, ulcers and gastrointestinal bleeding have been reported. MSK also describes a hypertension case and an observational pancreatitis signal; neither establishes how frequently harm occurs. Laboratory interaction findings involving drug-metabolizing enzymes or transporters have uncertain clinical significance. Review medication use and gastrointestinal history with a clinician before considering it. [1]

Separate symptom scores from broader claims

A pain score is a specific outcome. It does not by itself show repaired cartilage, prevention of future disability or benefit across unrelated pain conditions. Keep those questions separate when comparing an advertisement with a study abstract. This page does not recommend a product or a dosing schedule.

Devil’s claw: pain research and the limits of mixed formulas — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Memorial Sloan Kettering Cancer Center — Devil’s claw
    Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.